Europe’s biotech sector continues to face significant financing challenges, especially during growth and scale‑up. As the EU moves forward with the landmark Biotech Act, this webinar explores the funding tools available today, how companies can access them, and what changes are needed to expand investment in European biotech.

The session will provide an overview of current EU public and blended finance options across the development pipeline, explain how the European Investment Bank evaluates and supports biotech projects, and offer first-hand insights from a biotech founder on securing funding from idea to market. It will also examine how upcoming EU initiatives could improve access to capital and attract more private investment.

Speakers include:

Felicitas Riedl, Director of Innovation and Competitiveness at the European Investment Bank

Raffael Wohlgensinger, Founder & CEO, Formo

Jessica Martinsson, our moderator and CEO of SwedenBIO, the Swedish Biotech Association

Register here to the event: https://www.europabio.org/event/navigating-biotech-sme-funding-whats-available-how-it-works-whats-next-for-europe/ [1]